FLASH
Shkruar nga Pamfleti
"Only thanks to the insurance did I have the opportunity to be treated abroad and continue to be treated abroad," begins a health insurance beneficiary's testimony to a national television station.
Private health insurance helps you financially cope with illnesses that would otherwise be unaffordable.
A sixty-year-old citizen, whose identity has been protected, recounted to television his experience as a beneficiary of private health insurance.
"If I had not had private insurance with SIGAL, it would be a big question mark whether I would still be alive today, because I would not have had the financial means, neither personally nor as a family, to be treated abroad."
In the third year of insurance, the patient was diagnosed with a very rare tumor.
Health insurance at SIGAL also enables Target Personalized Oncology Therapy, based on genetic analysis of the tumor, a cutting-edge method.
"The cost of treatment was extremely high. Initially, the preventive was about 4,000 euros every three weeks, as the immunotherapy session was held every three weeks. Then, according to the new immunotherapy and targeted therapy scheme, the cost reached about 8,500–9,000 euros every 28 days.
"Initially, the treatment was expected to last about a year to a year and a half. However, given the progress of the disease and the medical assessments, it was deemed reasonable to extend it into a second phase," says the citizen, now a patient and regular follower of a very expensive innovative therapy.
Financial security is also a guarantee of family peace.
"On the other hand, my family feels calm and secure, because I know that, from a financial point of view, my treatment continues to be covered by SIGAL. Precisely because of my experience, other family members are also insured by SIGAL," the patient added to his testimony.
What is targeted therapy?
Thanks to health insurance at SIGAL INSURANCE GROUP, one of the most important innovations in contemporary medicine is accessible to patients from Albania.
Target Therapy, the most advanced and personalized treatment against oncological diseases, is a reality.
This treatment, with health insurance at SIGAL, is performed in the most specialized centers in Europe.
The method is based on detailed analysis of tumor DNA and RNA to precisely identify the factors that drive the disease in each patient.
This way, doctors can determine the most effective therapy, with fewer side effects and better results in a shorter time.
Cells affected by the tumor are targeted and healthy ones are "spared".
Compensation, proof of correctness
In the first five months of this year, SIGAL in Albania has paid out around 1.5 million euros in health insurance claims, half of all industry payments in the country.
SIGAL INSURANCE GROUP, in all three countries in the region, for the first five months of 2026, January-May, has paid out over 22 million euros in compensation to over 30 thousand beneficiaries in life and non-life insurance.
Lini një Përgjigje